SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 118 filers reported holding SANA BIOTECHNOLOGY INC in Q1 2023. The put-call ratio across all filers is 3.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $406,021 | -34.2% | 104,915 | +1.3% | 0.00% | – |
| Q2 2023 | $617,050 | +76.5% | 103,532 | -3.2% | 0.00% | – |
| Q1 2023 | $349,569 | +131.5% | 106,902 | +179.7% | 0.00% | – |
| Q4 2022 | $150,997 | -34.6% | 38,227 | -0.6% | 0.00% | – |
| Q3 2022 | $231,000 | -95.2% | 38,454 | -94.9% | 0.00% | -100.0% |
| Q2 2022 | $4,824,000 | +1471.3% | 750,198 | +1917.0% | 0.00% | – |
| Q1 2022 | $307,000 | -44.8% | 37,193 | +3.6% | 0.00% | – |
| Q4 2021 | $556,000 | -16.9% | 35,913 | +20.8% | 0.00% | – |
| Q3 2021 | $669,000 | -18.8% | 29,729 | +20.7% | 0.00% | – |
| Q1 2021 | $824,000 | – | 24,633 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 34,239,018 | $220,158,000 | 8.29% |
| Crestline Management, LP | 3,365,624 | $21,641,000 | 2.82% |
| Omega Fund Management, LLC | 843,750 | $5,425,000 | 1.73% |
| Alphabet Inc. | 2,812,500 | $18,084,000 | 0.98% |
| HARVARD MANAGEMENT CO INC | 468,749 | $3,014,000 | 0.35% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 6,400,000 | $41,152,000 | 0.35% |
| PFM Health Sciences, LP | 952,733 | $6,126,000 | 0.23% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 156,254 | $1,005,000 | 0.20% |
| Viewpoint Capital Management LLC | 23,545 | $151,000 | 0.14% |
| Artal Group S.A. | 400,000 | $2,572,000 | 0.14% |